Pentwater Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Pentwater Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,552,000	Closed	-$1.8B	–	165
2023 Q3	$1.8B	Buy	15,552,000 +2,825,100	+22%	+$304M	17.32%	4
2023 Q2	$1.31B	Buy	12,726,900 +6,626,900	+109%	+$699M	16.38%	4
2023 Q1	$666M	Buy	6,100,000 +2,560,344	+72%	+$283M	11.05%	3
2022 Q4	$403M	Buy	+3,539,656	New	+$294M	12.63%	4
2015 Q4	–	Sell	-20,000	Closed	-$396K	–	159
2015 Q3	$396K	Buy	+20,000	New	+$632K	0.01%	125

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return